Serum cytokines levels in Graves' disease

Saudi Medical Journal

Volumn 21, Issue 7, 2000, Pages 639-644

  Al Humaidi, Mohammed A ^a  

^a KING KHALID UNIVERSITY   (Saudi Arabia)

Author keywords

Graves' disease; Serum cytokines

Indexed keywords

CYTOKINE; THYROXINE;

ADULT; ARTICLE; BLOOD; CASE CONTROL STUDY; FEMALE; GRAVES DISEASE; HUMAN; MALE; THYROTOXICOSIS;

ADULT; CASE-CONTROL STUDIES; CYTOKINES; FEMALE; GRAVES DISEASE; HUMANS; MALE; THYROTOXICOSIS; THYROXINE;

EID: 0011058592     PISSN: 03795284     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Burman KD, Baker JR Jr Burman KD, Baker JR Jr. Immune mechanisms in Graves' disease. Endocr Rev 1985; 6: 183-232.
2. Nagataki-S, Eguchi-K. Cytokines and immune regulation in thyroid autoimmunity. Autoimmunity 1992; 13: 27-34.
3. Watson PF, Pickerill AP, Davies R, Weetman AP. Analysis of cytokine gene expression in Graves' disease and multinodular goiter. J Clin Endocrinol Metab 1994; 79: 355-360.
4. R Pashke, F Schuppen, M Taton, T Velu. Intrathyroidal cytokine gene expression profiles in autoimmune thyroiditis. J Endocrinology 1994; 141: 309-315.
5. Heuer M, Aust G, Ode-Hakim S. Scherbaum WA. Different cytokine mRNA profiles in Graves' disease. Hashimoto's thyroiditis, and nonautoimmune thyroid disorders determined by quantitative reverse transcriptase polymerase chain reaction (RT-PCR). Thyroid 1996; 6: 97-106.
6. Fisfalen ME, Palmer EM, Van Seventer GA, Soltani K, Sawai Y et al. Thyrotropin-receptor and thyroid peroxidase-specific T cell clones and their cytokine profile in autoimmune thyroid disease. J Clin Endocrinol Metab 1997; 82: 3655-3663.
7. Salvi M, Girasole G. Pedrazzoni M, Passeri M, Giuliani N, Minelli R et al. Increased serum concentrations of interleukin-6 (IL-6) and soluble IL-6 receptor in patients with Graves' disease. J Clin Endocrinol Metab 1996; 81: 2976-2979.
8. Al Humaidi MA. Serum Cytokines in autoimmune and toxic multinodular thyroid diseases. Saudi Medical Journal 1999; 20: 516-520.
9. Bartalena L, Brogioni S, Grasso L. Rago T, Vitti P, Pinchera A et al. Interleukin-6: A marker of thyroid-destructive processes? J Clin Endocrinol Metab 1994; 79: 1424-1427.
10. Cclik I, Akalin S, Erbas T. Serum levels of interleukin 6 and tumor necrosis factor-alpha in hyperthyroid patients before and after propylthiouracil treatment. European Journal of Endocrinology 1995; 132: 668-672.
11. Sato K, Sato HT, Shizume K, Ozawa M, Han DC, Imamura H et al. Inhibition of 1251 organification and thyroid hormone release by interleukin-1, tumor necrosis factor-alpha and interferon-gamma in human thyrocytes in suspension culture. J Clin Endocrinol Metab 1990; 70: 1735-1743.
12. Sayinalp S, Akalin S, Sayinalp N, Erbas T, Bayraktar M, Ozcebe OI et al. Serum immunoglobulin E and soluble CD23 in-patients with Graves' disease. Hormone & Metabolic Research 1996; 28: 133-137.
13. Bansal AS, Oilier W, Marsh MN, Pumphrey RS, Wilson PB. Variations in serum sCD23 in conditions with either enhanced humoral or cell-mediated immunity. Immunology 1993; 79: 285-289.
14. Komorowski J, Jankiewicz J, Robak T, Blasinska-Morawiec M, Stepien H. Cytokines serum levels as the markers of thyroid activation in Graves' disease. Immunol Lett 1998; 60: 143-148.
15. Koukkou E, Panayiotidis P, Alevizou-Terzaki V, Thalassinos N. High levels of serum soluble interleukin-2 receptors in hyperthyroid patients: correlation with serum thyroid hormones and independence from the etiology of the hyperthyroidism. J Clin Endocrinol Metab 1991; 73: 771-776.
16. Mariotti S, Caturegli P, Barbesino G, Marino M, Del-Prete GF, Chiovato L et al. Thyroid function and thyroid autoimmunity independently modulate serum concentration of soluble interleukin 2 (IL-2) receptor (sIL-2R) in thyroid diseases. Clin Endocrinol Oxf 1992; 37: 415-422.
17. Escobar-Morreale HF, Serrano-Gotarredona J, Villar LM, Garcia-Robles R, Gonzalez-Porque P, Sancho JM, Varela C. Methimazole has no dose-related effect on the serum concentrations of soluble class I major histocompatibility complex antigens, soluble interleukin-2 receptor, and beta 2-microglobulin in patients with Graves' disease. Thyroid 1996; 6: 29-36.
18. Murakami S, Kobayashi A, Kuma K, Murai H, Okamura Y, Satomi A, Ishida K. Serum-soluble interleukin-2 receptor levels before and after surgical treatment for Graves' disease. Surgery Today 1995; 25: 55-58.